Metrodora Therapeutics, Inc.
Edit

Metrodora Therapeutics, Inc.

http://www.metrodora.com/
Last activity: 28.03.2025
Probably Closed
Categories: BioTechCultureHealthTechMedtechServiceSpecialty
Metrodora Therapeutics is dedicated to treating inflammation, infection and microbiome dysregulation. Our specialty focus thereby includes a commitment to serving the health and medical needs of people throughout their lives, and particularly so during vulnerable stages such as pregnancy, preterm birth and old age. Because the well-being of our patients is the core element of our mission, we consciously and routinely foster a patient-centric culture. Our culture is biased toward action, with an unbending commitment to service and excellence through innovation.
Followers
201
Mentions
5
Location: United States, Washington, Seattle
Employees: 11-50

Mentions in press and media 5

DateTitleDescription
28.03.2025Polish Bioinformatics Firm Intelliseq Secures €4.5M to Revolutionize Genomic AnalysisIn the realm of healthcare, data is the new gold. The Polish bioinformatics company Intelliseq has struck a rich vein, securing €4.5 million in funding to propel its genomic data analysis capabilities. This investment, led by Vinci HiTech a...
28.03.2025Polish Intelliseq Lands €4.5M to Advance Genomic Data AnalysisPoland ~ Company: Polish bioinformatics company Intelliseq, specializing in the automated analysis and interpretation of variations in the human genome sequence, has secured €4.5 million in its latest funding round. The investment was led b...
28.03.2025Intelliseq secures €4.5M to enhance DNA analysis and genetic diagnosticsPolish bioinformatics company Intelliseq, has secured €4.5 million (PLN19 million) in its latest funding round. Clinical genomics transforms the way diseases are diagnosed and treated. Next-generation sequencing (NGS) has unlocked an unprec...
23.12.2024Bluenote's $10 Million Bet: A Leap into AI-Driven Life SciencesIn the bustling world of life sciences, time is often the enemy. Regulatory hurdles can stretch timelines, delaying the delivery of life-saving treatments. Enter Bluenote, a San Francisco-based startup that has just secured $10 million in f...
23.12.2024Bluenote Raises $10M in FundingBluenote, a San Francisco, CA-based generative AI platform for life sciences companies, raised $10M in financing. The round was led by Lux Capital, with participation from Elad Gil, Anthropic & Menlo Ventures Anthology Fund, McKesson Ve...

Reviews 0

Sign up to leave a review

Sign up Log In